These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12039847)

  • 21. Ultrastructural localization of aquaporin 4 and alpha1-syntrophin in the vascular feet of brain astrocytes.
    Inoue M; Wakayama Y; Liu JW; Murahashi M; Shibuya S; Oniki H
    Tohoku J Exp Med; 2002 Jun; 197(2):87-93. PubMed ID: 12233788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unraveling the mysteries of Duchenne and Becker muscular dystrophy.
    Hyser CL
    Mol Chem Neuropathol; 1989 Feb; 10(1):15-20. PubMed ID: 2660836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of neural stem cells from dystrophic mdx mouse.
    Annese T; Corsi P; Ruggieri S; Tamma R; Marinaccio C; Picocci S; Errede M; Specchia G; De Luca A; Frassanito MA; Desantis V; Vacca A; Ribatti D; Nico B
    Exp Cell Res; 2016 May; 343(2):190-207. PubMed ID: 27015747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.
    Capitanio D; Moriggi M; Torretta E; Barbacini P; De Palma S; Viganò A; Lochmüller H; Muntoni F; Ferlini A; Mora M; Gelfi C
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):547-563. PubMed ID: 31991054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A high-throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies.
    Scaglioni D; Ellis M; Catapano F; Torelli S; Chambers D; Feng L; Sewry C; Morgan J; Muntoni F; Phadke R
    Acta Neuropathol Commun; 2020 Apr; 8(1):53. PubMed ID: 32303261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dystrobrevin dynamics in muscle-cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy?
    Blake DJ
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S110-7. PubMed ID: 12206805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y; Nonaka I; Hirai S; Ozawa E
    J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.
    Bonilla E; Samitt CE; Miranda AF; Hays AP; Salviati G; DiMauro S; Kunkel LM; Hoffman EP; Rowland LP
    Cell; 1988 Aug; 54(4):447-52. PubMed ID: 3042151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of connective tissue growth factor in progressive muscular dystrophy].
    Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glial dystrophin-associated proteins, laminin and agrin, are downregulated in the brain of mdx mouse.
    Nico B; Tamma R; Annese T; Mangieri D; De Luca A; Corsi P; Benagiano V; Longo V; Crivellato E; Salmaggi A; Ribatti D
    Lab Invest; 2010 Nov; 90(11):1645-60. PubMed ID: 20714324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.
    Matsumura K; Nonaka I; Tomé FM; Arahata K; Collin H; Leturcq F; Récan D; Kaplan JC; Fardeau M; Campbell KP
    Am J Hum Genet; 1993 Aug; 53(2):409-16. PubMed ID: 8328458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach.
    Freund AA; Scola RH; Arndt RC; Lorenzoni PJ; Kay CK; Werneck LC
    Arq Neuropsiquiatr; 2007 Mar; 65(1):73-6. PubMed ID: 17420831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein.
    Neely JD; Amiry-Moghaddam M; Ottersen OP; Froehner SC; Agre P; Adams ME
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14108-13. PubMed ID: 11717465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered aquaporin 4 expression in muscles of Fukuyama-type congenital muscular dystrophy.
    Wakayama Y; Jimi T; Inoue M; Kojima H; Yamashita S; Kumagai T; Murahashi M; Hara H; Shibuya S
    Virchows Arch; 2003 Dec; 443(6):761-7. PubMed ID: 12942324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decorin and biglycan expression is differentially altered in several muscular dystrophies.
    Zanotti S; Negri T; Cappelletti C; Bernasconi P; Canioni E; Di Blasi C; Pegoraro E; Angelini C; Ciscato P; Prelle A; Mantegazza R; Morandi L; Mora M
    Brain; 2005 Nov; 128(Pt 11):2546-55. PubMed ID: 16183658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autosomal recessive distal muscular dystrophy: normal expression of dystrophin, utrophin and dystrophin-associated proteins in muscle fibers.
    Yamanouchi Y; Ozawa E; Nonaka I
    J Neurol Sci; 1994 Oct; 126(1):70-6. PubMed ID: 7836950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced expression of aquaporin 4 in human muscles with amyotrophic lateral sclerosis and other neurogenic atrophies.
    Jimi T; Wakayama Y; Matsuzaki Y; Hara H; Inoue M; Shibuya S
    Pathol Res Pract; 2004; 200(3):203-9. PubMed ID: 15200272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
    Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
    J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic study of vinculin in Duchenne muscular dystrophy.
    Minetti C; Tanji K; Bonilla E
    Neurology; 1992 Sep; 42(9):1751-4. PubMed ID: 1513465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies.
    Soblechero-Martín P; López-Martínez A; de la Puente-Ovejero L; Vallejo-Illarramendi A; Arechavala-Gomeza V
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):711-723. PubMed ID: 33999469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.